Summary
President Donald Trump is expected to announce a new program to cover CBD (cannabidiol) treatments under Medicare. This move might also involve changes in marijuana regulation in the United States. CBD is used by many for managing pain, anxiety, and sleep issues.
Key Facts
- President Trump may announce a program that will allow Medicare to cover CBD treatments next year.
- CBD is a compound used by millions in the U.S. for pain and anxiety management.
- Trump might also change how marijuana is classified, which could affect taxes, businesses, and medical treatments.
- The possible reclassification of marijuana could make it similar to Tylenol with codeine, a less strict category than drugs like heroin.
- The Centers for Medicare & Medicaid Services (CMS) could run this CBD coverage as a pilot program.
- The program is reported to target cancer treatment, palliative care, and possibly chronic pain.
- The program is expected to involve strict controls on who qualifies and how CBD is prescribed.
- The intention is to evaluate whether CBD can become part of official medical coverage, potentially reducing costs for seniors.
